Often available in latex-free versions. Each nebuliser set is supplied with a medication chamber, drive line tubing and a face mask.

Latex-free versions are available. Each nebuliser set includes a medication chamber, drive line tubing and a face mask.

Latex-free versions are available. Each nebuliser set includes a medication chamber, drive line tubing and a face mask.

Mucolytic to facilitate expectoration by reducing sputum viscosity.

Nebusal 7%
Inhalation of nebulised solution, 4 ml, up to twice daily.

Non-sedating antihistamine.

• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.

Long-acting selective beta2 agonist.

Reversible airways obstruction in patients requiring long-term regular bronchodilator therapy
Nocturnal asthma in patients requiring long-term regular bronchodilator therapy
Prevention of exercise-induced bronchospasm in patients requiring long-term regular bronchodilator therapy
Chronic asthma only in patients who regularly use an inhaled corticosteroid (not for immediate relief of acute asthma)
By inhalation of aerosol, or by inhalation of powder
• Child 5–11 years: 50 mcg, twice daily.
• Over 12 years: by inhalation, 50 mcg twice daily. Up to 100 mcg twice daily for more severe airway obstruction.

For COPD by inhalation of aerosol, or by inhalation of powder
• Adult: 50 mcg (2 puffs or 1 blister), twice daily.

Nicotine replacement therapy (NRT) can be used:
• to replace cigarettes after total cessation of smoking
• to reduce the number of cigarettes smoked in the lead-up to cessation
• to treat cravings and reduce compensatory smoking that might take place after a period of time in a no-smoking environment.

Nicotine replacement therapy (NRT) can be used:
• to replace cigarettes after total cessation of smoking
• to reduce the number of cigarettes smoked in the lead-up to cessation
• to treat cravings and reduce compensatory smoking that might take place after a period of time in a no-smoking environment.

NIOX is a widely used, non-invasive, point-of-care medical technology that enables clinicians to objectively assess airway inflammation with a quick and accurate measure of fractional exhaled nitric oxide (FeNO).
Exhalation flow control ensures measurement results are only delivered if the test has been carried out correctly in the correct conditions.
The NIOX VERO is suitable for both adults and children (age 4 and above), and features patient facing display, 2 exhalation modes, measurement result memory, and is service and maintenance free.

Nicotine replacement therapy (NRT) can be used:
• to replace cigarettes after total cessation of smoking
• to reduce the number of cigarettes smoked in the lead-up to cessation
• to treat cravings and reduce compensatory smoking that might take place after a period of time in a no-smoking environment.